These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4445996)

  • 21. Effect of heparin and Bivalirudin on the kinetics of clot formation: Viscoelastic coagulation testing.
    Hasija S; Kapoor PM
    Ann Card Anaesth; 2017; 20(1):122. PubMed ID: 28074815
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanism of inactivation of trypsin by antithrombin.
    Danielsson A; Björk I
    Biochem J; 1982 Oct; 207(1):21-8. PubMed ID: 6817749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.
    Rao LV; Rapaport SI
    Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6687-91. PubMed ID: 3261869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The inhibitor of F VIIa in plasma measured with a sensitive chromogenic substrate assay: comparison with antithrombin, protein C and heparin cofactor II in a clinical material.
    Abildgaard U; Sandset PM; Andersson TR; Odegaard OR; Rosĕn S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):274-7. PubMed ID: 2465215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of rabbit thrombomodulin on the inhibition of thrombin by the antithrombin-heparin complex: role of the acid domain of thrombomodulin].
    Bourin MC
    C R Acad Sci III; 1987; 304(8):173-6. PubMed ID: 3028582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.
    Mauray S; de Raucourt E; Talbot JC; Dachary-Prigent J; Jozefowicz M; Fischer AM
    Biochim Biophys Acta; 1998 Sep; 1387(1-2):184-94. PubMed ID: 9748565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the effect of heparin on factor V and factor VII complex in the human circulation].
    HENGSTMANN H; BECKER M
    Dtsch Arch Klin Med; 1962; 207():637-51. PubMed ID: 13906442
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of heparin on prothrombinic activity, on circulatory anticoagulants (antithromboplastin, plasma and serum antithrombin, antifibrinogen, on utilization of prothrombin, on conversion and acceleration factors in prothrombin conversion, on proteinemia, and on protein fraction].
    MARRAZZA P; DI GIROLAMO L
    Arch Sci Med (Torino); 1952 Jan; 93(1):9-16. PubMed ID: 14944438
    [No Abstract]   [Full Text] [Related]  

  • 29. Heparin and calcium ions dramatically enhance antithrombin reactivity with factor IXa by generating new interaction exosites.
    Bedsted T; Swanson R; Chuang YJ; Bock PE; Björk I; Olson ST
    Biochemistry; 2003 Jul; 42(27):8143-52. PubMed ID: 12846563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the activated Cls subunit of the first component of complement by antithrombin III in the presence of heparin.
    Ogston D; Murray J; Crawford GP
    Thromb Res; 1976 Sep; 9(3):217-222. PubMed ID: 982345
    [No Abstract]   [Full Text] [Related]  

  • 31. The progressive antithrombin (antithrombin-III, heparin-cofactor).
    Pálos LA
    Haematologia (Budap); 1974; 8(1-4):455-9. PubMed ID: 4461431
    [No Abstract]   [Full Text] [Related]  

  • 32. Purification and properties of guinea pig antithrombin III.
    Heck L; Rosenberg R; Remold H
    Prep Biochem; 1979; 9(4):359-77. PubMed ID: 504072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection of factor Xa from neutralization by the heparin-antithrombin complex.
    Teitel JM; Rosenberg RD
    J Clin Invest; 1983 May; 71(5):1383-91. PubMed ID: 6222069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous inactivation of thrombin and factor Xa by AT-III: influence of heparin.
    Odegård OR; Lie M
    Thromb Res; 1978 Apr; 12(4):697-700. PubMed ID: 663903
    [No Abstract]   [Full Text] [Related]  

  • 36. Relationships between antithrombin activity, anticoagulant efficacy of heparin therapy and perioperative variables in patients undergoing cardiac surgery requiring cardiopulmonary bypass.
    Muedra V; Bonanad S; Gómez M; Villalonga V; Sánchez F; Llopis JE
    Perfusion; 2011 Nov; 26(6):487-95. PubMed ID: 21665912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The antithrombin effect of heparin; role of heparin concentration].
    BURSTEIN M
    C R Seances Soc Biol Fil; 1952 May; 146(9-10):641-2. PubMed ID: 12998196
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of protamine on heparin-antithrombin III complexes. In vitro studies.
    Kitani T; Nagarajan SC; Shanberge JN
    Thromb Res; 1980 Feb 1-15; 17(3-4):367-74. PubMed ID: 7368168
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of activated coagulation factor VII by normal human plasma.
    Dahl PE; Abildgaard U; Larsen ML; Tjensvoll L
    Thromb Haemost; 1982 Dec; 48(3):253-6. PubMed ID: 7164015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coagulation-fibrinolytic mechanism and the action of heparin.
    Rosenberg RD
    Adv Exp Med Biol; 1975; 52():217-37. PubMed ID: 235831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.